These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6944619)

  • 21. [Multiple drug treatment of Hodgkin's disease: the MOPP schedule].
    Singer Z; Dzieza-Lalowicz I; Kardaszewicz S; Rozek-Lesiak K
    Nowotwory; 1978; 28(2):203-8. PubMed ID: 683884
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
    Sinniah D; Lin HP
    Cancer; 1979 May; 43(5):1587-9. PubMed ID: 445354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 25. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 27. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 28. Skin infiltration in Hodgkin's disease.
    Gordon RA; Lookingbill DP; Abt AB
    Arch Dermatol; 1980 Sep; 116(9):1038-40. PubMed ID: 7416756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy of acute leukemia and Hodgkin's disease.
    Frei E
    JAMA; 1972 Nov; 222(9):1168. PubMed ID: 4678057
    [No Abstract]   [Full Text] [Related]  

  • 30. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Nissen NI; Stutzman L; Holland JF; Glidewell OJ
    Arch Intern Med; 1973 Mar; 131(3):396-401. PubMed ID: 4688038
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
    Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
    [No Abstract]   [Full Text] [Related]  

  • 33. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 34. The MOPP controversy.
    DiBiasio AG
    Eye Ear Nose Throat Mon; 1972 Dec; 51(12):459-60. PubMed ID: 4637961
    [No Abstract]   [Full Text] [Related]  

  • 35. The cure of disseminated Hodgkin's disease: prospects and problems.
    Streuli RA; Ultmann JE
    Ann Intern Med; 1980 May; 92(5):693-5. PubMed ID: 7387012
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
    Fisher RI; DeVita VT; Hubbard SP; Simon R; Young RC
    Ann Intern Med; 1979 May; 90(5):761-3. PubMed ID: 434676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K; Honda T; Hattori M
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

  • 39. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.
    Sullivan MP; Fuller LM; Chen T; Fisher R; Fryer C; Gehan E; Gilchrist GS; Hays D; Hanson W; Heller R; Higgins G; Jenkin D; Kung F; Sheehan W; Tefft M; Ternberg J; Wharam M
    Cancer Treat Rep; 1982 Apr; 66(4):937-47. PubMed ID: 7042092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.